MarketBeat Instant News Alerts 2 hours agoWeiss Ratings Reaffirms Sell (D) Rating for Ashland (NYSE:ASH)MarketBeatWeiss Ratings restated a "sell (d)" rating on shares of Ashland in a report on Friday.NYSE:ASHRead Weiss Ratings Reaffirms Sell (D) Rating for Ashland (NYSE:ASH)2 hours agoWeiss Ratings Reiterates "Sell (D+)" Rating for ASGN (NYSE:ASGN)MarketBeatWeiss Ratings restated a "sell (d+)" rating on shares of ASGN in a research note on Friday.NYSE:ASGNRead Weiss Ratings Reiterates "Sell (D+)" Rating for ASGN (NYSE:ASGN)2 hours agoASE Technology (NYSE:ASX) Earns Hold (C) Rating from Weiss RatingsMarketBeatWeiss Ratings restated a "hold (c)" rating on shares of ASE Technology in a research note on Friday.NYSE:ASXRead ASE Technology (NYSE:ASX) Earns Hold (C) Rating from Weiss Ratings2 hours agoAscendis Pharma A/S (NASDAQ:ASND) Given Sell (D-) Rating at Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of Ascendis Pharma A/S in a research report on Friday.NASDAQ:ASNDRead Ascendis Pharma A/S (NASDAQ:ASND) Given Sell (D-) Rating at Weiss Ratings2 hours agoAsana (NYSE:ASAN) Earns "Sell (E+)" Rating from Weiss RatingsMarketBeatWeiss Ratings restated a "sell (e+)" rating on shares of Asana in a report on Friday.NYSE:ASANRead Asana (NYSE:ASAN) Earns "Sell (E+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Arvinas (NASDAQ:ARVN)MarketBeatWeiss Ratings reiterated a "sell (e+)" rating on shares of Arvinas in a report on Friday.NASDAQ:ARVNRead Weiss Ratings Reiterates Sell (E+) Rating for Arvinas (NASDAQ:ARVN) Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) Stock Price Down 4.9% - Here's What Happened3Nebius Group (NBIS) to Release Earnings on Wednesday4Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock5Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why6Nebius Group (NASDAQ:NBIS) Shares Down 3.9% - Time to Sell?7Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened8CoreWeave (NASDAQ:CRWV) Stock Price Down 7.2% After Insider Selling All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoArtivion (NYSE:AORT) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNYSE:AORTRead Artivion (NYSE:AORT) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoArtesian Resources' (ARTNA) Hold (C-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ARTNARead Artesian Resources' (ARTNA) Hold (C-) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for ARS Pharmaceuticals (NASDAQ:SPRY)MarketBeatNASDAQ:SPRYRead Weiss Ratings Reaffirms Sell (D-) Rating for ARS Pharmaceuticals (NASDAQ:SPRY)2 hours agoArrowhead Pharmaceuticals (NASDAQ:ARWR) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:ARWRRead Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives Sell (D-) Rating from Weiss Ratings2 hours agoArrow Financial (NASDAQ:AROW) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNASDAQ:AROWRead Arrow Financial (NASDAQ:AROW) Given "Hold (C)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C)" Rating for Arrow Electronics (NYSE:ARW)MarketBeatNYSE:ARWRead Weiss Ratings Reiterates "Hold (C)" Rating for Arrow Electronics (NYSE:ARW)2 hours agoArriVent BioPharma (NASDAQ:AVBP) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:AVBPRead ArriVent BioPharma (NASDAQ:AVBP) Earns Sell (D-) Rating from Weiss Ratings2 hours agoArrive AI's (ARAI) Sell (E-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ARAIRead Arrive AI's (ARAI) Sell (E-) Rating Reiterated at Weiss Ratings2 hours agoArqit Quantum (NASDAQ:ARQQ) Earns Sell (D) Rating from Weiss RatingsMarketBeatNASDAQ:ARQQRead Arqit Quantum (NASDAQ:ARQQ) Earns Sell (D) Rating from Weiss Ratings2 hours agoARQ (NASDAQ:ARQ) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:ARQRead ARQ (NASDAQ:ARQ) Receives Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B) Rating for Armstrong World Industries (NYSE:AWI)MarketBeatNYSE:AWIRead Weiss Ratings Reaffirms Buy (B) Rating for Armstrong World Industries (NYSE:AWI)2 hours agoARMOUR Residential REIT (NYSE:ARR) Receives "Sell (D)" Rating from Weiss RatingsMarketBeatNYSE:ARRRead ARMOUR Residential REIT (NYSE:ARR) Receives "Sell (D)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Arlo Technologies (NYSE:ARLO)MarketBeatNYSE:ARLORead Weiss Ratings Reaffirms Sell (D-) Rating for Arlo Technologies (NYSE:ARLO)2 hours agoWeiss Ratings Reaffirms Hold (C) Rating for Arhaus (NASDAQ:ARHS)MarketBeatNASDAQ:ARHSRead Weiss Ratings Reaffirms Hold (C) Rating for Arhaus (NASDAQ:ARHS)2 hours agoargenex's (ARGX) Hold (C) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ARGXRead argenex's (ARGX) Hold (C) Rating Reiterated at Weiss Ratings2 hours agoArdmore Shipping (NYSE:ASC) Earns Hold (C) Rating from Weiss RatingsMarketBeatNYSE:ASCRead Ardmore Shipping (NYSE:ASC) Earns Hold (C) Rating from Weiss Ratings2 hours agoArdent Health (NYSE:ARDT) Upgraded at Weiss RatingsMarketBeatNYSE:ARDTRead Ardent Health (NYSE:ARDT) Upgraded at Weiss Ratings2 hours agoArdelyx (NASDAQ:ARDX) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:ARDXRead Ardelyx (NASDAQ:ARDX) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoArdagh Metal Packaging's (AMBP) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:AMBPRead Ardagh Metal Packaging's (AMBP) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoArcus Biosciences (NYSE:RCUS) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNYSE:RCUSRead Arcus Biosciences (NYSE:RCUS) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoArcturus Therapeutics (NASDAQ:ARCT) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:ARCTRead Arcturus Therapeutics (NASDAQ:ARCT) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D+)" Rating for Arcos Dorados (NYSE:ARCO)MarketBeatNYSE:ARCORead Weiss Ratings Reaffirms "Sell (D+)" Rating for Arcos Dorados (NYSE:ARCO)2 hours agoArchrock's (AROC) Buy (B) Rating Reiterated at Weiss RatingsMarketBeatNYSE:AROCRead Archrock's (AROC) Buy (B) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C)" Rating for ArcelorMittal (NYSE:MT)MarketBeatNYSE:MTRead Weiss Ratings Reiterates "Hold (C)" Rating for ArcelorMittal (NYSE:MT) Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025This dark force is about to change everythingFrom Porter & Company (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 20252 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Move $1,000 into this stock before Nov 6From Altimetry (Ad)The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
